Skip to content
sellWeak10b5-1 plan

Lewis William sold $1.9M of INSM

Chair and CEO at INSMED Inc. 25,580 shares at an average of $72.98, traded Dec 12, 2024, filed Dec 13, 2024.

Warning score
15
Value
$1.9M
25,580 shares
Holdings after
233,924
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001628280-24-051195, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 12, 2024MOption exercise
Common Stock10b5-1
+18,750$22.76$427k403,710Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stock10b5-1
-11,504$72.58$835k392,206Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stock10b5-1
-6,847$73.56$504k385,359Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stock10b5-1
-399$74.23$30k384,960Dec 13, 2024
Dec 12, 2024MOption exercise
Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1
+6,830$10.85$74k240,754Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1
-4,087$72.57$297k236,667Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1
-2,562$73.55$188k234,105Dec 13, 2024
Dec 12, 2024SOpen-market sale
Common Stockindirect: By the Katie Procter Dynasty Trust10b5-1
-181$74.22$13k233,924Dec 13, 2024
Dec 12, 2024MOption exercise
Stock Option (right to buy)derivative10b5-1
-18,750$0.00$0131,250Dec 13, 2024
Dec 12, 2024MOption exercise
Stock Option (right to buy)derivativeindirect: By the Katie Procter Dynasty Trust10b5-1
-6,830$0.00$0239,120Dec 13, 2024

Related signals

Other insiders at INSMED Inc and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
15Weaksell10b5-1INSM
INSMED Inc
Lewis William
Chair and CEO
$1.8M25,580

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.